Georgia Medicare Pulmonary Rehabilitation Benefit

::: hero

By Brevy Care Team · Last verified May 13, 2026

Pulmonary rehabilitation is one of the most cost-effective and most underutilized interventions in chronic disease management. For Medicare beneficiaries with moderate to very severe COPD (GOLD Stage II through IV), a structured 36-session pulmonary rehabilitation program reduces hospital readmissions by roughly 40 percent, improves exercise capacity by an average of 50 to 80 meters on the six-minute walk test, reduces dyspnea, improves quality of life on validated instruments, and improves self-management of respiratory disease. Yet fewer than 5 percent of eligible Medicare beneficiaries actually participate, and Georgia, which has one of the highest COPD prevalence rates in the country, has participation rates that lag the national average in many rural counties.

This guide explains the federal statutory architecture of the Medicare pulmonary rehabilitation benefit under Section 1861(fff) of the Social Security Act, the implementing regulation at 42 CFR 410.47, the National Coverage Determination 240.8, the GOLD II-IV COPD qualifying condition, the 2019 expansion of supervision authority to physician assistants and nurse practitioners under Section 51008 of the Bipartisan Budget Act of 2018, the 2022 Consolidated Appropriations Act expansion of Secretary authority to designate additional qualifying conditions, and the 2024 CMS Outpatient Prospective Payment System Final Rule coverage of post-COVID-19 pulmonary dysfunction. We will work through six detailed case examples and fourteen common mistakes that keep Georgia families from accessing the pulmonary rehab care they qualify for.

The pulmonary rehabilitation benefit is the companion benefit to cardiac rehabilitation, established by the same 2006 legislation (Section 144 of the Medicare Improvements and Extension Act of 2006, Public Law 109-432), governed by parallel regulatory frameworks, and supervised under identical authority since the BBA 2018 expansion. The two benefits are often discussed together by clinicians and policymakers, and beneficiaries who qualify for one sometimes qualify for the other based on overlapping cardiopulmonary disease. :::

::: callout Key Takeaways

1. Medicare pulmonary rehabilitation services are covered under Section 1861(fff) of the Social Security Act and the implementing regulation at 42 CFR 410.47. The benefit was established by Section 144 of the Medicare Improvements and Extension Act of 2006 (Public Law 109-432), the same legislation that established cardiac rehabilitation. National Coverage Determination 240.8 governs program standards.

2. The primary qualifying condition is moderate to very severe COPD as defined by Global Initiative for Chronic Obstructive Lung Disease (GOLD) staging: FEV1/FVC less than 70 percent post-bronchodilator and FEV1 less than 80 percent of predicted. This includes GOLD Stage II (FEV1 50 to 79 percent), GOLD Stage III (FEV1 30 to 49 percent), and GOLD Stage IV (FEV1 less than 30 percent).

3. The benefit provides up to 36 one-hour sessions, with extension to 72 sessions when medically necessary and documented by the physician. Sessions can be delivered up to two per day, allowing concentrated participation for beneficiaries who travel to the program.

4. Section 4108 of the Consolidated Appropriations Act 2022 (Public Law 117-103) expanded the Secretary's authority to designate additional qualifying conditions beyond COPD. CMS used this authority in the 2024 OPPS Final Rule to add coverage for post-COVID-19 pulmonary dysfunction (long COVID with respiratory symptoms). Some Medicare Administrative Contractors have also issued Local Coverage Determinations adding other progressive respiratory diseases (interstitial lung disease, bronchiectasis, alpha-1 antitrypsin deficiency, lung transplant candidacy) as qualifying conditions under Secretary authority.

5. Section 51008 of the Bipartisan Budget Act of 2018 (Public Law 115-123), effective January 1, 2019, expanded supervision authority for pulmonary rehabilitation (in parallel with cardiac rehabilitation) to allow physician assistants, nurse practitioners, and clinical nurse specialists to supervise PR in addition to physicians. This expansion has been particularly important for access in rural Georgia.

6. Pulmonary rehab programs include four required components under 42 CFR 410.47(c): physician-prescribed exercise, education or training closely related to the patient's care and treatment, psychosocial assessment, and outcomes assessment. The individualized treatment plan must be reviewed by the physician every 30 days.

7. Pulmonary rehab is paid under OPPS using HCPCS G0424 (pulmonary rehabilitation including exercise, with or without continuous oximetry, per session) at approximately $59 per session for calendar year 2026, wage-index adjusted. Beneficiary cost-sharing is the standard Part B 20 percent coinsurance after the $257 Part B deductible. Medigap Plan G covers the coinsurance fully.

8. Georgia beneficiaries access pulmonary rehabilitation through major health systems including Emory Healthcare, Piedmont Healthcare, Wellstar Health System, Northeast Georgia Health System, Memorial Health, AU Medical Center, Atrium Health Navicent, Phoebe Putney, Grady Health System, Tanner Health System, and certain critical access hospitals across rural Georgia. Palmetto GBA serves as the Medicare Administrative Contractor for Jurisdiction J (Alabama, Georgia, Tennessee). :::

Federal Statutory and Regulatory Framework

Section 1861(fff): The Pulmonary Rehabilitation Statutory Authority

Section 1861(fff) of the Social Security Act is the foundational statutory authority for the Medicare pulmonary rehabilitation benefit. Added by Section 144 of the Medicare Improvements and Extension Act of 2006 (Division B of the Tax Relief and Health Care Act, Public Law 109-432), Section 1861(fff) defines pulmonary rehabilitation as a physician-supervised program furnishing a defined set of services to beneficiaries with qualifying respiratory conditions. The same legislation enacted Section 1861(eee) establishing the cardiac rehabilitation benefit, and the two benefits have closely parallel statutory and regulatory architectures.

The four-subsection structure of Section 1861(fff) is:

1. Section 1861(fff)(1): Defines pulmonary rehabilitation as a physician-supervised program with four required components.
2. Section 1861(fff)(2): Specifies the components: physician-prescribed exercise, education or training, psychosocial assessment, and outcomes assessment.
3. Section 1861(fff)(3): Specifies the qualifying conditions (originally limited to moderate to very severe COPD; expanded under Secretary authority).
4. Section 1861(fff) other: Other operational requirements including the individualized treatment plan reviewed by physician every 30 days and the requirement that services be furnished in a hospital outpatient department or physician's office.

42 CFR 410.47: Conditions of Coverage

The implementing regulation at 42 CFR 410.47 spells out the operational rules for pulmonary rehabilitation. Key elements:

Qualifying Conditions (42 CFR 410.47(b))

The primary qualifying condition is moderate to very severe COPD as defined by Global Initiative for Chronic Obstructive Lung Disease (GOLD) staging:

1. GOLD Stage II (Moderate COPD): FEV1/FVC less than 70 percent post-bronchodilator, and FEV1 50 percent or more but less than 80 percent of predicted.
2. GOLD Stage III (Severe COPD): FEV1/FVC less than 70 percent, and FEV1 30 percent or more but less than 50 percent of predicted.
3. GOLD Stage IV (Very Severe COPD): FEV1/FVC less than 70 percent, and FEV1 less than 30 percent of predicted (or less than 50 percent with chronic respiratory failure).

The diagnosis of COPD must be made by spirometry showing the obstructive pattern (post-bronchodilator FEV1/FVC less than 70 percent). The severity classification is based on the FEV1 percent of predicted.

Under the CAA 2022 expansion of Secretary authority, CMS added coverage for additional qualifying conditions in the 2024 OPPS Final Rule, including patients with confirmed or suspected post-COVID-19 condition with respiratory symptoms (long COVID/PASC with respiratory dysfunction). Some MACs have issued Local Coverage Determinations adding other progressive respiratory diseases as qualifying conditions.

Components of Pulmonary Rehab (42 CFR 410.47(c))

A qualifying pulmonary rehabilitation program must include four components:

1. Physician-prescribed exercise: Aerobic exercise, strength training, and breathing exercises. Continuous pulse oximetry monitoring during exercise. Supplemental oxygen titration as needed.

2. Education or training closely related to the patient's care and treatment: COPD pathophysiology, inhaler technique, smoking cessation, nutrition, energy conservation, breathing techniques (pursed-lip and diaphragmatic), bronchopulmonary hygiene, action plans for exacerbations, and end-of-life planning.

3. Psychosocial assessment: Depression screening (PHQ-9), anxiety screening (GAD-7), quality of life assessment, social support, and health literacy evaluation.

4. Outcomes assessment: 6-minute walk distance, dyspnea scales (Borg, BDI/TDI), quality of life (St. George's Respiratory Questionnaire, COPD Assessment Test), and BODE Index.

The individualized treatment plan integrates the four components and must be reviewed by a physician every 30 days.

Setting (42 CFR 410.47(d))

PR services may be furnished in a hospital outpatient department or a physician's office. Most programs are hospital outpatient department-based, paid under OPPS. Office-based programs are paid under MPFS.

Frequency and Duration (42 CFR 410.47(g))

• Up to two 1-hour sessions per day
• Up to 36 sessions over the course of the program
• Up to 72 sessions when medically necessary and documented by the physician

Supervision

Direct supervision is required. The supervising clinician must be in the office suite and immediately available. As of January 1, 2019, under Section 51008 of the Bipartisan Budget Act of 2018, physician assistants, nurse practitioners, and clinical nurse specialists may supervise pulmonary rehab in addition to physicians.

NCD 240.8: Pulmonary Rehabilitation Programs

National Coverage Determination 240.8 governs Medicare's coverage of comprehensive pulmonary rehabilitation programs. Effective for services on or after January 1, 2010, NCD 240.8 codified the program standards and qualifying conditions. The NCD has been updated to reflect statutory changes and CMS rulemaking, including the 2024 OPPS Final Rule expansion to post-COVID pulmonary dysfunction.

CAA 2022 Section 4108: Secretary Authority Expansion

Section 4108 of the Consolidated Appropriations Act 2022 (Public Law 117-103) expanded the Secretary's authority under Section 1861(fff)(3) to designate additional qualifying conditions for pulmonary rehabilitation beyond COPD. Before CAA 2022, the only qualifying condition was moderate to very severe COPD; the statute did not contemplate other progressive respiratory diseases.

CMS used this expanded authority in the calendar year 2024 OPPS Final Rule to add coverage for:

1. Patients with confirmed or suspected post-COVID-19 condition (long COVID, post-acute sequelae of SARS-CoV-2 infection, PASC) with respiratory symptoms.
2. Other conditions on a case-by-case basis per MAC discretion, allowing local coverage determinations to add additional progressive respiratory diseases.

For Georgia, Palmetto GBA Jurisdiction J has issued Local Coverage Determinations and articles addressing PR coverage for additional conditions. Each MAC's LCD applies to the providers within its jurisdiction.

BBA 2018 Section 51008: Non-Physician Practitioner Supervision

Section 51008 of the Bipartisan Budget Act of 2018 (Public Law 115-123), effective January 1, 2019, amended Section 1861(fff) to expand supervision authority for pulmonary rehabilitation. The same provision expanded supervision authority for cardiac rehabilitation under Section 1861(eee). Before January 1, 2019, only physicians could provide the direct supervision required for PR. The BBA 2018 expansion added physician assistants (PAs), nurse practitioners (NPs), and clinical nurse specialists (CNSs) as authorized supervisors.

This expansion has been particularly valuable for access in rural Georgia, where many hospitals have limited physician availability for direct supervision of rehabilitation programs. The expansion allows PA-, NP-, or CNS-led pulmonary rehab programs to provide direct supervision while a physician maintains overall program direction.

Section 1862(a)(1)(A): Reasonable and Necessary

Section 1862(a)(1)(A) is the general "reasonable and necessary" coverage limitation. PR services must be reasonable and necessary for the qualifying respiratory condition. The medical record must document the qualifying condition (including spirometry for COPD, with the FEV1/FVC ratio and FEV1 percent predicted), the medical necessity for PR, and the individualized treatment plan.

Billing Codes and Payment Structure

Pulmonary Rehab Codes

The primary code for comprehensive pulmonary rehabilitation under NCD 240.8 is:

• HCPCS G0424: Pulmonary rehabilitation, including exercise (includes monitoring), one hour, per session, up to two sessions per day.

Other respiratory therapy codes that may be used in different contexts (not the comprehensive PR benefit) include:

• G0237: Therapeutic procedures to increase strength or endurance of respiratory muscles, one-on-one, each 15 minutes
• G0238: Therapeutic procedures other than G0237, one-on-one, each 15 minutes
• G0239: Therapeutic procedures for two or more individuals (group), face-to-face

The G0237/G0238/G0239 codes are typically used for respiratory therapy that does not meet the comprehensive PR program requirements under NCD 240.8.

OPPS Payment

G0424 is paid under OPPS APC 5731 (Level 1 Minor Procedures) at approximately $59 per session for calendar year 2026, wage-index adjusted. This is substantially lower than the cardiac rehabilitation APC payment (approximately $110 to $135 per session), a disparity that has been the subject of ongoing advocacy efforts by the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) and the American Thoracic Society (ATS).

Beneficiary Cost-Sharing

For Pulmonary Rehab:

• Part B deductible: $257 in 2026
• Coinsurance: 20 percent of the Medicare-approved amount after the deductible
• Per-session out-of-pocket (before Medigap): approximately $11 to $13
• 36-session course: approximately $400 to $500 total out-of-pocket before Medigap
• 72-session course: approximately $800 to $1,000 total out-of-pocket before Medigap

Medigap Plan G or grandfathered Plan F covers the coinsurance fully. Medigap Plan N covers the coinsurance subject to a $20 per visit copay (which exceeds the actual coinsurance amount, so the $20 copay applies).

Components of Pulmonary Rehabilitation

A qualifying pulmonary rehabilitation program delivers four required components on each session day:

Exercise Training

The exercise component is individualized based on the beneficiary's baseline exercise capacity, oxygen needs, comorbidities, and rehabilitation goals. Typical sessions include 30 to 45 minutes of supervised aerobic exercise on equipment such as treadmills, stationary bicycles, recumbent steppers, and arm ergometers. Strength training for upper and lower extremities is increasingly incorporated. Continuous pulse oximetry monitoring is provided throughout exercise. Supplemental oxygen is titrated to maintain oxygen saturation at or above 88 to 90 percent during exercise.

Many COPD patients require more supplemental oxygen during exertion than at rest, and PR is the optimal setting to identify and titrate exertional oxygen needs. Some patients who do not require home oxygen at rest may need ambulatory oxygen for activities of daily living, and PR identifies this need through supervised exercise testing.

Education and Training

The education component addresses COPD self-management skills:

1. COPD pathophysiology: Understanding the disease mechanism, the role of airflow obstruction, and the importance of avoiding triggers (smoke, infection, air pollution).

2. Inhaler technique: Correct technique for metered-dose inhalers (MDI), dry powder inhalers (DPI), soft mist inhalers (SMI), and nebulizers. Poor inhaler technique is widespread; even experienced patients frequently make errors that reduce drug delivery.

3. Smoking cessation: Intensive counseling, pharmacotherapy options (nicotine replacement, varenicline, bupropion), and ongoing support.

4. Nutrition: For obese patients, weight loss counseling. For cachectic patients, weight gain strategies. For all patients, nutrient density and timing recommendations.

5. Energy conservation and pacing: Techniques for accomplishing daily tasks while minimizing dyspnea.

6. Breathing techniques: Pursed-lip breathing, diaphragmatic breathing, breath pacing during activity.

7. Bronchopulmonary hygiene: Postural drainage, percussion, and devices such as Acapella valve, Flutter valve, or high-frequency chest wall oscillation vests.

8. Action plans for exacerbations: Recognition of warning signs, when to use rescue medications, when to start a course of oral corticosteroids and antibiotics, when to call the physician, when to go to the ED.

9. End-of-life planning and advance directives: For severe COPD, the trajectory of the disease and discussions of goals of care.

Psychosocial Assessment

Depression and anxiety are common in COPD, affecting 20 to 40 percent of patients. PR programs use standardized screening:

• PHQ-9 (Patient Health Questionnaire-9): Depression screening
• GAD-7 (Generalized Anxiety Disorder-7): Anxiety screening
• COPD Assessment Test (CAT): Overall symptom and quality of life impact
• St. George's Respiratory Questionnaire (SGRQ): COPD-specific quality of life

Identified psychosocial concerns are addressed within the program through counseling and behavioral intervention, or referred to appropriate clinicians.

Outcomes Assessment

PR programs document outcomes at baseline and program completion using validated measures:

1. 6-minute walk distance: The standard measure of exercise capacity. Improvements of 30 to 50 meters or more are clinically meaningful.

2. Dyspnea (Borg scale, BDI/TDI): Self-reported breathlessness severity.

3. Quality of life (SGRQ, CAT): Validated COPD-specific instruments. Improvements above the minimal clinically important difference (4 points on SGRQ, 2 points on CAT) are clinically meaningful.

4. BODE Index: Composite of BMI, Obstruction (FEV1 percent predicted), Dyspnea, and Exercise capacity. BODE score predicts mortality and is used for risk stratification.

Qualifying Conditions Detail

COPD GOLD Staging

The primary qualifying condition is moderate to very severe COPD as defined by GOLD staging.

GOLD Stage II (Moderate COPD): FEV1 50 to 79 percent of predicted. Symptoms typically include exertional dyspnea, chronic cough, and sputum production. Many patients have not yet sought medical attention or have been managed primarily by primary care.

GOLD Stage III (Severe COPD): FEV1 30 to 49 percent of predicted. More substantial dyspnea limiting activity. Most patients are under pulmonologist care and on multiple inhaled medications.

GOLD Stage IV (Very Severe COPD): FEV1 less than 30 percent of predicted (or less than 50 percent with chronic respiratory failure). Severe dyspnea at rest or with minimal activity. Often requires supplemental oxygen.

The diagnosis must be supported by post-bronchodilator spirometry showing the obstructive pattern.

Post-COVID Pulmonary Rehabilitation

Under the CAA 2022 expansion of Secretary authority and the CMS 2024 OPPS Final Rule, Medicare added coverage for pulmonary rehabilitation for patients with confirmed or suspected post-COVID-19 condition with respiratory symptoms. This includes patients with:

• Persistent dyspnea after acute COVID-19 infection
• Hypoxia or exercise-induced desaturation
• Documented pulmonary function abnormalities on spirometry, lung volumes, or diffusing capacity
• Imaging findings of post-COVID lung disease
• Reduced exercise capacity

Coverage criteria and documentation requirements vary by MAC. Palmetto GBA Jurisdiction J has issued guidance addressing these expanded qualifying conditions.

Other Qualifying Conditions Under Secretary Authority

Under the CAA 2022 expansion, some MACs have issued LCDs adding the following as qualifying conditions on a case-by-case basis:

1. Interstitial lung disease (ILD): Including idiopathic pulmonary fibrosis (IPF), nonspecific interstitial pneumonia (NSIP), hypersensitivity pneumonitis, and connective tissue disease-associated ILDs.

2. Bronchiectasis: Including non-cystic fibrosis bronchiectasis. Cystic fibrosis in older adult Medicare beneficiaries is rare but increasing.

3. Alpha-1 antitrypsin deficiency: Genetic form of COPD/emphysema.

4. Lung volume reduction surgery (LVRS) candidacy or post-LVRS: As part of preparation for or recovery from LVRS.

5. Lung transplant candidacy or post-transplant: For pretransplant rehabilitation or posttransplant recovery.

6. Severe pulmonary hypertension: Selective cases.

Coverage for these additional conditions varies by MAC. The treating pulmonologist must document the medical necessity and the expected benefit of pulmonary rehabilitation.

Georgia Pulmonary Rehabilitation Provider Landscape

Emory Healthcare

Emory operates pulmonary rehabilitation programs at multiple sites including Emory Saint Joseph's Hospital, Emory University Hospital, Emory Decatur Hospital, and other sites. The Emory Pulmonary Hypertension Center and Emory Lung Transplant Program serve patients with complex pulmonary conditions including pulmonary hypertension and post-transplant rehabilitation.

Piedmont Healthcare

Piedmont offers pulmonary rehabilitation at Piedmont Atlanta, Piedmont Athens Regional, Piedmont Columbus Regional, Piedmont Augusta, Piedmont Macon Medical Center, Piedmont Newnan, Piedmont Fayette, and other sites across the system.

Wellstar Health System

Wellstar operates pulmonary rehabilitation programs at Wellstar Kennestone Regional Medical Center, Wellstar Cobb Hospital, Wellstar Douglas Hospital, Wellstar Spalding Regional, Wellstar West Georgia, and other locations.

Northeast Georgia Health System

NGHS offers pulmonary rehabilitation at Northeast Georgia Medical Center Gainesville and NGMC Braselton, serving the rapidly growing North Georgia region with high rates of COPD.

Memorial Health

Memorial Health University Medical Center in Savannah operates pulmonary rehabilitation programs serving coastal Georgia.

AU Medical Center (Wellstar MCG Health)

Augusta University Medical Center operates pulmonary rehabilitation as part of the Medical College of Georgia's pulmonary and critical care program. AU MCG has an Adult Cystic Fibrosis Program and serves patients with complex pulmonary conditions.

Atrium Health Navicent

Atrium Navicent in Macon operates pulmonary rehabilitation programs serving central Georgia.

Phoebe Putney Health System

Phoebe Putney Memorial Hospital in Albany operates pulmonary rehabilitation programs serving southwest Georgia.

Grady Health System

Grady Memorial Hospital in Atlanta operates pulmonary rehabilitation as part of its comprehensive pulmonology program.

Tanner Health System

Tanner Medical Center in Carrollton operates pulmonary rehabilitation serving west Georgia.

Rural Hospitals and Critical Access Hospitals

Many of Georgia's 37 critical access hospitals and other rural facilities have begun offering pulmonary rehabilitation since the BBA 2018 supervision expansion. Availability varies, but the trajectory has been toward improved rural access.

COPD Epidemiology in Georgia

Georgia has one of the higher COPD prevalence rates in the United States, driven by historic high tobacco use rates, rural healthcare access barriers, an aging population, and environmental exposures including textile dust (historic), poultry processing dust, and agricultural dust. The Centers for Disease Control and Prevention estimates that 7 to 9 percent of Georgia adults have COPD, with higher rates in rural counties in southwest and southeast Georgia. Despite this high disease burden, Medicare pulmonary rehabilitation participation among eligible Georgia beneficiaries is estimated below 5 percent, far below the level that would maximize clinical and economic benefit.

Worked Example 1: Margaret, 78, Atlanta, COPD GOLD III Post-Exacerbation Pulmonary Rehab at Piedmont Atlanta

Margaret is 78, lives in Atlanta, has traditional Medicare with a Medigap Plan G supplement. She has long-standing COPD from a 40-pack-year smoking history (she quit at age 65). Her most recent spirometry shows FEV1/FVC of 55 percent and FEV1 of 42 percent of predicted (GOLD Stage III, Severe COPD). She is on triple inhaled therapy with a long-acting muscarinic antagonist (LAMA), long-acting beta-agonist (LABA), and inhaled corticosteroid (ICS) combination, plus albuterol as needed.

Three weeks ago, Margaret had a COPD exacerbation triggered by an upper respiratory tract infection. She was hospitalized at Piedmont Atlanta Hospital for 4 days, requiring IV corticosteroids, broad-spectrum antibiotics, and noninvasive ventilation (BiPAP) overnight for hypercapnic respiratory failure. She was discharged with oral corticosteroid taper, completion of an antibiotic course, and a referral to pulmonary rehabilitation.

Margaret qualifies for pulmonary rehab under 42 CFR 410.47(b) based on her moderate-to-severe COPD (GOLD III). Her pulmonologist Dr. Williams refers her to the Piedmont Atlanta Pulmonary Rehabilitation Program. The intake includes a comprehensive evaluation by a respiratory therapist and exercise physiologist, baseline measurements (6-minute walk distance of 240 meters, COPD Assessment Test score of 26, supplemental oxygen requirement of 2 liters per minute with exertion), risk factor assessment (former smoker, low BMI of 22 indicating mild cachexia), and psychosocial screening (PHQ-9 score 8 for mild depression, GAD-7 score 6 for normal anxiety).

Margaret enrolls in the program at 3 sessions per week, starting 4 weeks after her hospital discharge. Each session is 60 minutes including warm-up, supervised aerobic exercise on treadmill and recumbent stepper with continuous pulse oximetry, light strength training, cool-down, and educational sessions covering breathing techniques, inhaler technique reinforcement, nutritional counseling, and action planning for future exacerbations.

Each session is billed under HCPCS G0424 at approximately $59 OPPS wage-adjusted for Atlanta (wage index ~0.95), so approximately $56 per session. Margaret has met her Part B deductible from earlier physician visits. She owes 20 percent coinsurance, approximately $11 per session, covered fully by Medigap Plan G. Margaret's out-of-pocket per session: $0.

Margaret completes 36 sessions over 12 weeks. Her 6-minute walk distance improves from 240 meters at baseline to 380 meters at completion. Her COPD Assessment Test score improves from 26 to 16. Her dyspnea on exertion improves substantially. Her PHQ-9 score improves to 3 (normal). She has not been rehospitalized in the 90 days since program completion.

Margaret's total out-of-pocket cost for 36 sessions: $0 (Medigap covers entirely).

Worked Example 2: Robert, 82, Savannah, Severe Emphysema Pulmonary Rehab at Memorial Health

Robert is 82, lives in Savannah, has traditional Medicare with a Medigap Plan G supplement. He has severe emphysema with FEV1 25 percent of predicted (GOLD Stage IV) and chronic hypoxic respiratory failure on home oxygen 2 liters per minute continuous. He has had two COPD exacerbations requiring hospitalization in the past 6 months.

Robert's pulmonologist at Memorial Health University Medical Center refers him to pulmonary rehabilitation. He qualifies under 42 CFR 410.47(b) for GOLD IV very severe COPD.

Robert enrolls in the Memorial Health Pulmonary Rehab Program. Sessions are billed under G0424 at approximately $56 wage-adjusted for Savannah (wage index ~0.88, so approximately $52 per session). 20 percent coinsurance approximately $10 per session, covered fully by Medigap Plan G. OOP per session: $0.

Robert's sessions include supervised aerobic exercise with continuous pulse oximetry, supplemental oxygen titration (his oxygen requirement increases to 4 liters per minute during exercise to maintain saturation above 88 percent), education on COPD self-management, reinforcement of inhaler technique on his LAMA/LABA/ICS combination, nutritional counseling (he is cachectic at BMI 19), and intensive review of his action plan for future exacerbations.

Robert completes 36 sessions over 12 weeks. His exercise capacity improves from 1.5 METs at baseline to 2.8 METs at completion. His dyspnea on minimal exertion improves. He requires fewer rescue albuterol doses per day. His self-management confidence is substantially improved. He continues to require home oxygen, but his quality of life is meaningfully better.

Worked Example 3: Linda, 75, Macon, COPD GOLD II Pulmonary Rehab at Atrium Health Navicent

Linda is 75, lives in Macon, has traditional Medicare with a Medigap Plan G supplement. She has COPD GOLD II with FEV1 65 percent of predicted. She is a current smoker, smoking 15 cigarettes per day, and presents with progressive exertional dyspnea limiting her ability to walk to her mailbox without resting.

Her pulmonologist at Atrium Health Navicent refers Linda to pulmonary rehabilitation. She qualifies under 42 CFR 410.47(b) with GOLD II moderate COPD.

Linda enrolls in the Atrium Navicent PR Program. Sessions billed under G0424 at approximately $52 wage-adjusted for Macon. 20 percent coinsurance approximately $10, covered by Medigap Plan G. OOP per session: $0.

In addition to standard PR components, Linda receives intensive smoking cessation counseling. The PR registered nurse provides motivational interviewing across the 12-week program, the program psychologist provides cognitive behavioral support, and Linda is started on varenicline (Chantix) at week two. By week six, Linda has successfully quit smoking. Her FEV1 measured at program completion has improved modestly to 70 percent of predicted (still GOLD II but moving toward better lung function with smoking cessation).

Linda's 6-minute walk distance improves from 320 meters to 460 meters. Her CAT score improves from 18 to 9. She has reclaimed her daily walking routine. She remains smoke-free at 3-month follow-up.

Worked Example 4: Charles, 80, Augusta, Post-COVID Pulmonary Impairment at AU Medical (New CAA 2022 Expansion Coverage)

Charles is 80, lives in Augusta, has traditional Medicare with a Medigap Plan G supplement. He had severe COVID-19 pneumonia in February 2025 requiring 14-day hospitalization at AU Medical Center, including 7 days of mechanical ventilation in the ICU. He survived and was eventually discharged, but he has persistent post-COVID respiratory symptoms: dyspnea on minimal exertion (NYHA-equivalent class III), oxygen desaturation to 88 percent with walking 100 feet, and abnormal pulmonary function tests showing restrictive pattern (FEV1 60 percent, FVC 55 percent) with reduced diffusing capacity (DLCO 45 percent).

Counterfactual: before the CAA 2022 Secretary authority expansion and the CMS 2024 OPPS Final Rule, Charles would not have qualified for pulmonary rehab. He does not have COPD; he has post-COVID-19 pulmonary dysfunction. The Section 1861(fff)(3) qualifying condition list was originally limited to moderate to very severe COPD.

Under the CAA 2022 expansion (Section 4108 of Public Law 117-103) and the CMS 2024 OPPS Final Rule coverage of post-COVID respiratory dysfunction, Charles qualifies for pulmonary rehab. His pulmonologist at AU Medical Center documents the medical necessity and refers him to the AU Medical Center Pulmonary Rehab Program.

Charles enrolls in the program at 3 sessions per week. Sessions billed under G0424 at approximately $55 wage-adjusted for the Augusta MSA. 20 percent coinsurance approximately $11, covered fully by Medigap Plan G. OOP per session: $0.

Charles completes the standard 36-session course and then receives a physician-documented extension to 54 sessions due to continued measurable improvement. His 6-minute walk distance improves from 180 meters at baseline to 360 meters at week 36 and to 420 meters at session 54. His resting oxygen requirement decreases from 2 LPM continuous to no supplemental oxygen at rest (he continues to use 2 LPM for exertion). His CAT score improves from 24 to 11.

Worked Example 5: Patricia, 73, Columbus, IPF Pulmonary Rehab at Piedmont Columbus

Patricia is 73, lives in Columbus, has traditional Medicare with a Medigap Plan N supplement. She was diagnosed with idiopathic pulmonary fibrosis (IPF) 18 months ago after presenting with progressive dyspnea and a characteristic honeycombing pattern on high-resolution CT chest. She is on antifibrotic therapy with pirfenidone, which has modestly slowed her FVC decline. Her current FVC is 62 percent of predicted and DLCO is 38 percent of predicted.

IPF was not on the original Section 1861(fff)(3) qualifying condition list. Under the CAA 2022 Secretary authority expansion and Palmetto GBA Jurisdiction J Local Coverage Determination, some MACs have approved pulmonary rehabilitation for IPF and other interstitial lung diseases as "other conditions" eligible for coverage on a case-by-case basis.

Patricia's pulmonologist at Piedmont Columbus Regional documents the medical necessity of pulmonary rehab for IPF, citing evidence that PR improves exercise capacity, dyspnea, and quality of life in IPF patients. The request is approved by Palmetto GBA.

Patricia enrolls in the Piedmont Columbus PR Program. Sessions billed under G0424 at approximately $55 wage-adjusted. 20 percent coinsurance approximately $11.

Medigap Plan N covers the coinsurance subject to a $20 per visit copay (waived for ED visits not resulting in admission). Patricia's $11 coinsurance is fully offset by Medigap, but the $20 per visit copay applies (since Plan N copay exceeds coinsurance amount). Patricia's OOP per session: $20. 36 sessions x $20 = $720 OOP for the full program.

Counterfactual: had Patricia chosen Medigap Plan G instead of Plan N, her OOP for PR would have been $0. Medigap Plan N's $20 per visit copay is the trade-off for the lower monthly premium.

Patricia completes 36 sessions. Her exercise capacity improves modestly (the IPF natural history is progressive decline). Her quality of life on the SGRQ improves substantially. Her self-management skills improve. PR does not change the underlying IPF disease course, but it improves her functional status and resilience to her progressive disease.

Worked Example 6: Henry, 85, Athens, Alpha-1 Antitrypsin Deficiency Pulmonary Rehab at Northeast Georgia Medical Center

Henry is 85, lives in Athens, has traditional Medicare with a Medigap Plan G supplement. He was diagnosed with alpha-1 antitrypsin deficiency (Z homozygous genotype) at age 60 after recurrent COPD-like symptoms despite a minimal smoking history. He has developed severe emphysema with FEV1 35 percent of predicted (GOLD III to IV depending on the year of measurement). He is on weekly intravenous alpha-1 proteinase inhibitor augmentation therapy (Aralast NP or Prolastin-C) administered at home by a home infusion nurse.

Henry qualifies for pulmonary rehab under 42 CFR 410.47(b) based on his severe COPD/emphysema (regardless of the underlying alpha-1 etiology). His pulmonologist at Northeast Georgia Medical Center Athens refers him to the NGMC Athens Pulmonary Rehab Program.

Henry enrolls at 3 sessions per week. Sessions billed under G0424 at approximately $55 wage-adjusted. 20 percent coinsurance approximately $11, covered fully by Medigap Plan G. OOP per session: $0.

Henry completes the standard 36-session course plus a physician-documented extension to 60 sessions due to continued improvement and his complex underlying disease. The program includes education on the interaction between his alpha-1 deficiency, his oxygen needs, his augmentation therapy schedule, and his prognosis. Henry's 6-minute walk distance improves from 200 meters to 340 meters. His CAT score improves from 22 to 13.

Fourteen Common Mistakes Georgia Beneficiaries and Families Make

Mistake 1: Not knowing pulmonary rehabilitation is a Medicare benefit

Awareness is the largest barrier to pulmonary rehabilitation participation. Fewer than 5 percent of eligible Medicare beneficiaries participate. If you have moderate to very severe COPD or other qualifying respiratory disease, ask your pulmonologist or primary care physician about pulmonary rehabilitation.

Mistake 2: Not knowing about post-COVID PR coverage

The CAA 2022 expansion of Secretary authority and the CMS 2024 OPPS Final Rule added coverage for post-COVID-19 pulmonary dysfunction. Many beneficiaries and even some clinicians are unaware of this expansion. If you have persistent respiratory symptoms after COVID-19, ask about PR.

Mistake 3: Confusing PR with general physical therapy

Pulmonary rehabilitation is a specialized pulmonary-specific program with supervised exercise, education on respiratory self-management, psychosocial assessment, and outcomes measurement, governed by Section 1861(fff) and 42 CFR 410.47. General outpatient physical therapy is governed by different regulations and uses different billing.

Mistake 4: Stopping at 36 sessions when 72 may be approved

Under 42 CFR 410.47(g), pulmonary rehab can be extended from 36 to 72 sessions when medically necessary and documented by the physician. Don't stop at 36 sessions if your physician believes additional sessions would benefit you.

Mistake 5: Not asking about supplemental oxygen titration during PR

Pulmonary rehabilitation is the optimal setting to titrate supplemental oxygen needs during exercise. Many COPD patients need more supplemental oxygen during exertion than at rest. Some patients who do not require home oxygen at rest may need ambulatory oxygen for activities of daily living, and PR is where this need can be safely identified and titrated.

Mistake 6: Missing the smoking cessation opportunity

Pulmonary rehab includes intensive smoking cessation counseling. Quit rates during PR are higher than in general clinical settings due to the structured, supportive program environment and the daily reinforcement of respiratory health concepts.

Mistake 7: Not appealing a PR denial for non-COPD conditions

Under the CAA 2022 Secretary authority expansion, additional qualifying conditions can be approved on a case-by-case basis. Appeals for interstitial lung disease, post-COVID respiratory dysfunction, alpha-1 antitrypsin deficiency, and other progressive respiratory diseases can sometimes succeed with strong physician documentation.

Mistake 8: Assuming physician supervision is required

Since January 1, 2019, under Section 51008 of the Bipartisan Budget Act of 2018, physician assistants, nurse practitioners, and clinical nurse specialists can supervise pulmonary rehab. This expansion has improved access in rural Georgia.

Mistake 9: Confusing inpatient hospitalization for COPD exacerbation with outpatient pulmonary rehab

Inpatient hospitalization for COPD exacerbation provides acute treatment of the exacerbation. Pulmonary rehab is the outpatient structured rehabilitation program that should follow stabilization. The two are complementary, not substitutes.

Mistake 10: Not utilizing the multidisciplinary team

Pulmonary rehab teams include nurses, respiratory therapists, exercise physiologists, dietitians, sometimes social workers and pharmacists. These team members are valuable resources for questions about medication management, breathing technique, dietary changes, exercise progression, emotional adjustment, and self-management.

Mistake 11: Not engaging with breathing technique training

Pursed-lip breathing, diaphragmatic breathing, and breath pacing during activity are foundational skills that produce immediate, measurable improvements in dyspnea. Many COPD patients have heard of these techniques but have never been formally taught and practiced under supervision.

Mistake 12: Missing inhaler technique reinforcement

Poor inhaler technique is widespread among COPD patients. Studies show that 60 to 90 percent of patients make at least one critical error in inhaler technique, reducing drug delivery and disease control. Pulmonary rehab is an ideal opportunity to identify and correct technique errors.

Mistake 13: Not coordinating with primary pulmonologist

Pulmonary rehab should complement, not replace, ongoing pulmonary management by a pulmonologist or primary care physician. Communication between the PR team and the treating physician is important for medication adjustments, oxygen prescription changes, and management of comorbidities.

Mistake 14: Not considering home-based or hybrid pulmonary rehab

Tele-pulmonary rehabilitation programs have emerged. Hybrid models with some in-person and some home-based sessions are growing. Pure home-based PR is not yet broadly covered, but the landscape is evolving. Ask your local PR program about their flexibility options.

Frequently Asked Questions

::: accordion

What is pulmonary rehabilitation?

Pulmonary rehabilitation is a physician-supervised program that includes physician-prescribed exercise, education or training closely related to respiratory disease management, psychosocial assessment, and outcomes assessment. It is designed to improve exercise capacity, reduce dyspnea, improve quality of life, and reduce hospital readmissions for beneficiaries with qualifying respiratory conditions.

What is the statutory basis for Medicare pulmonary rehab coverage?

Section 1861(fff) of the Social Security Act, added by Section 144 of the Medicare Improvements and Extension Act of 2006 (Public Law 109-432). The implementing regulation is at 42 CFR 410.47 and the National Coverage Determination is 240.8.

Who qualifies for Medicare pulmonary rehabilitation?

The primary qualifying condition is moderate to very severe COPD as defined by GOLD staging (GOLD II to IV: FEV1/FVC less than 70 percent and FEV1 less than 80 percent of predicted). Under the CAA 2022 expansion of Secretary authority and the CMS 2024 OPPS Final Rule, additional conditions are now covered including post-COVID-19 pulmonary dysfunction. Some MACs have issued LCDs adding other progressive respiratory diseases.

What is the GOLD staging system?

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) staging classifies COPD severity by post-bronchodilator FEV1 percent of predicted: GOLD I (Mild) 80 percent or more, GOLD II (Moderate) 50 to 79 percent, GOLD III (Severe) 30 to 49 percent, and GOLD IV (Very Severe) less than 30 percent. All stages require FEV1/FVC less than 70 percent post-bronchodilator confirming the obstructive pattern. Medicare PR covers GOLD II through IV.

How many pulmonary rehab sessions are covered?

Up to 36 one-hour sessions, with extension to 72 sessions when medically necessary and documented by the physician. Up to two sessions per day are allowed, supporting concentrated participation.

What does pulmonary rehab cost?

The Part B deductible is $257 in 2026, and after the deductible, beneficiaries owe 20 percent coinsurance per session. Out-of-pocket per session is approximately $11 to $13 (before Medigap). 36-session course total before Medigap is approximately $400 to $500. Medigap Plan G or grandfathered Plan F covers the coinsurance fully.

Are pulmonary rehab programs covered by Medicare Advantage?

Yes. Medicare Advantage plans must cover all Medicare-covered services including pulmonary rehabilitation. Cost-sharing structures vary by plan; many MA plans use flat copays per session.

What is the difference between PR and cardiac rehab?

Pulmonary rehab is for beneficiaries with qualifying respiratory conditions (primarily COPD); cardiac rehab is for beneficiaries with qualifying cardiac conditions. The two programs have parallel statutory frameworks (Sections 1861(fff) and 1861(eee), both added by MIEA-TRHCA 2006 Section 144), parallel regulatory frameworks (42 CFR 410.47 for PR, 42 CFR 410.49 for CR), and parallel supervision rules (BBA 2018 Section 51008 expanded both to PA/NP/CNS supervision). The curriculum, codes, and clinical focus differ.

What is included in a pulmonary rehab session?

Each session is approximately 60 minutes and includes warm-up, supervised aerobic exercise with continuous pulse oximetry, strength training, cool-down, supplemental oxygen titration as needed, and educational content on COPD self-management.

What kind of exercise does pulmonary rehab include?

Aerobic exercise on treadmill, stationary bicycle, recumbent stepper, or arm ergometer; strength training for upper and lower extremities; inspiratory muscle training (selective use); and breathing technique training.

What education is provided in pulmonary rehab?

COPD pathophysiology, inhaler technique, smoking cessation, nutrition (weight loss for obese, weight gain for cachectic), energy conservation and pacing, breathing techniques (pursed-lip and diaphragmatic), bronchopulmonary hygiene, action plans for exacerbations, and end-of-life planning and advance directives.

Who supervises pulmonary rehab?

Direct supervision is required and may be provided by physicians, physician assistants, nurse practitioners, or clinical nurse specialists. The expansion to PAs, NPs, and CNSs was enacted by Section 51008 of the Bipartisan Budget Act of 2018, effective January 1, 2019.

Can I do pulmonary rehab in a physician's office?

Yes. Section 1861(fff) and 42 CFR 410.47 allow pulmonary rehabilitation to be furnished in a physician's office or a hospital outpatient department. Most programs are hospital outpatient department-based, paid under OPPS at approximately $59 per session under G0424.

Can I do home-based or virtual pulmonary rehab?

Some programs offer hybrid models with home-based or virtual components for some sessions. Pure home-based or virtual pulmonary rehabilitation is not yet broadly covered, but the landscape is evolving following the COVID-19 pandemic. Ask your local program about their options.

How soon after a COPD exacerbation should I start pulmonary rehab?

Optimal initiation is generally 2 to 6 weeks after the hospitalization or exacerbation. Earlier initiation is sometimes appropriate when the patient is clinically stable. Delaying past 6 to 12 weeks reduces some of the benefit.

What is the evidence for pulmonary rehab effectiveness?

Multiple large randomized controlled trials and meta-analyses demonstrate that pulmonary rehabilitation reduces hospital readmissions by 30 to 50 percent, improves 6-minute walk distance by an average of 50 to 80 meters, improves dyspnea scores, improves quality of life, and reduces mortality risk. The evidence base is one of the strongest in chronic disease management.

Does pulmonary rehab cure COPD?

No. COPD is a progressive disease and PR does not cure it or reverse airflow obstruction. PR improves exercise capacity, reduces dyspnea, improves quality of life, improves self-management skills, and reduces hospital readmissions. The underlying disease continues to require ongoing pharmacological management.

What is the COPD Assessment Test (CAT)?

The CAT is an 8-item self-report instrument measuring the impact of COPD on a patient's life. Scores range from 0 to 40, with higher scores indicating greater impact. A 2-point change is the minimal clinically important difference. CAT is commonly used in PR programs to track outcomes.

What is the 6-minute walk test?

The 6-minute walk test measures the distance a patient walks on a flat indoor surface in 6 minutes. It is a standard measure of exercise capacity in pulmonary disease. Improvements of 30 to 50 meters or more across a course of PR are clinically meaningful.

Can I appeal a Medicare denial of pulmonary rehab?

Yes. Under Section 1869 of the Social Security Act, beneficiaries have a 5-level appeals process. For non-COPD qualifying conditions (post-COVID, ILD, alpha-1 deficiency, etc.), strong physician documentation of medical necessity supports approval under the CAA 2022 Secretary authority expansion.

Is pulmonary rehab covered for interstitial lung disease (ILD)?

Under the CAA 2022 expansion of Secretary authority and MAC-specific LCDs, some MACs have approved PR for ILD including idiopathic pulmonary fibrosis (IPF) on a case-by-case basis. Coverage varies by jurisdiction. Palmetto GBA Jurisdiction J (covering Alabama, Georgia, Tennessee) has issued guidance addressing PR coverage for additional conditions.

Is pulmonary rehab covered after lung transplantation?

Yes. Lung transplant candidacy and post-transplant recovery are commonly approved as qualifying conditions under MAC discretion. Pulmonary rehab is essentially standard of care for lung transplant patients.

Where do I find a pulmonary rehab program in Georgia?

Search the AACVPR (American Association of Cardiovascular and Pulmonary Rehabilitation) program directory at aacvpr.org, contact your pulmonologist or primary care physician for a referral, call the American Lung Association at 1-800-586-4872, or call GeorgiaCares at 1-866-552-4464 for guidance. Major Georgia health systems including Emory, Piedmont, Wellstar, NGHS, Memorial Health, AU Medical Center, Atrium Health Navicent, Phoebe Putney, Grady, and Tanner operate pulmonary rehab programs.

How do I prepare for pulmonary rehab?

Bring your inhaler list and inhalers, your home oxygen prescription (if applicable), recent pulmonary function test results, recent imaging, your current medication list, and a list of questions. Wear comfortable exercise clothing and athletic shoes. Bring water and a light snack. Most programs provide nebulizers, exercise equipment, and supplemental oxygen during sessions.

:::

::: cta

Get Help With Georgia Medicare Pulmonary Rehabilitation

If you have a qualifying respiratory condition and need help accessing pulmonary rehabilitation, the resources below can help:

1. Medicare: 1-800-MEDICARE (1-800-633-4227)
2. Palmetto GBA (Jurisdiction J MAC): 1-877-567-9230
3. Kepro QIO (Quality of Care, Premature Discharge): 1-844-455-8708
4. GeorgiaCares SHIP (Free Counseling): 1-866-552-4464
5. DCH Medicaid Member Services: 1-866-211-0950
6. American Lung Association: 1-800-586-4872
7. COPD Foundation: 1-866-316-2673
8. AACVPR (Pulmonary Rehab Provider Directory): 1-312-321-5146
9. Social Security Administration: 1-800-772-1213
10. HHS Office for Civil Rights: 1-800-368-1019
11. HHS Office of Inspector General Hotline: 1-800-447-8477
12. Medicare Rights Center: 1-800-333-4114
13. Center for Medicare Advocacy: 1-860-456-7790
14. Atlanta Legal Aid: 404-377-0701
15. Georgia Legal Services Program: 1-800-498-9469
16. 211 Georgia: Dial 2-1-1
17. Eldercare Locator: 1-800-677-1116
18. VA Benefits: 1-800-827-1000

For comprehensive eldercare guidance covering Medicare, Medicaid, VA benefits, caregiving, and senior respiratory health decisions, visit Brevy at brevy.com. The Brevy Care Team publishes state-specific deep dives covering every Medicare benefit category, every Medicaid pathway, and the on-the-ground provider landscape for families navigating eldercare in Georgia and across the country.

This guide is for informational purposes only and does not constitute legal, medical, or financial advice. Medicare rules change, and individual circumstances vary. Always verify current rules with Medicare, your Medicare Administrative Contractor (Palmetto GBA for Georgia), GeorgiaCares, your treating pulmonologist, or a qualified professional before making decisions about pulmonary rehabilitation or appeals.

:::